John Butler

Biography
With a strong background in advanced technology development John has spent over 30 years developing products for PCR based applications, and several technologies for studying the human genome, and most recently the development of a platform that advances disease research and clinical testing. For the last 10 years John has devoted his life to the development of a platform that delivers a set of capabilities to the cancer clinical testing market through the integration of digital pathology and NGS analysis. John teamed up with Quantumcytes CTO, Bidhan Chaudhuri, along with their network of scientists, engineers, computational biologists, business development professionals, as well as investors and scientific advisors to develop QCPRECISE, a product that brings spatial biology to the clinic to diagnose cancer a very unique way.

---

Talk
Digital Pathology Guided Spatial Microdissection
This talk will introduce Quantumcytes QCPRECISE technology that integrates digital pathology with molecular analysis for use in molecular pathology workflows. The system is capable of microdissection from ROIs down to 50 microns and is scalable for use in a clinical setting (100s of slidesshift). Clinical data will be presented.

Spatial Showcase:
Quantumcyte
Quantumcyte is an early stage technology company that develops products and workflows for the solid tissue clinical testing markets. The company is located in Sunyvale, CA.